	Bénéfice Avant Impôts		Date
Agios Pharmaceuticals	USD -109.06M	5.62M	2025-12
Alnylam Pharmaceuticals	USD 161.14M	77.83M	2025-12
Arrowhead Research	USD 28.27M	7.85M	2025-12
Astellas Pharma	JPY 133.96B	29.77B	2025-12
BioCryst Pharmaceuticals	USD -86.95M	73.5M	2024-12
BioMarin Pharmaceutical	USD -26.32M	324.19M	2025-09
Celltrion	KRW 14.6B	180.89B	2025-06
Cspc Pharmaceutical	CNY 1.21B	110.04M	2025-09
Divis Laboratories Ltd	INR 8.54B	580M	2025-12
Esperion Therapeutics	USD 67.66M	3.6M	2024-09
Exelixis	USD 252.69M	275K	2025-12
Halozyme Therapeutics	USD 218.96M	14.02M	2025-09
Ionis Pharmaceuticals	USD -228M	99M	2025-12
Kangmei Pharma	CNY 2.07M	13.77M	2025-09
Knight Therapeutics	CAD -1.92M	13.69M	2025-09
Laboratorios Farma	EUR 26.78M	94.77M	2025-06
Medical Developments International	AUD -149K	466K	2025-06
Moderna	USD -187M	631M	2025-09
Nektar Therapeutics	USD -37.05M	15.27M	2024-09
Neuren Pharmaceuticals	AUD 9.86M	161.24M	2025-06
Neurocrine Biosciences	USD 239.4M	52.4M	2025-12
Novartis	USD 4.2B	335M	2025-09
Omeros	USD -65.12M	21.27M	2024-06
OPKO Health	USD 41.43M	203.95M	2025-09
Organigram Holdings	CAD -41.72M	25.52M	2025-09
Pfizer	USD 3.33B	290M	2025-09
Pharma Mar	EUR -4.08M	27.43M	2025-09
PTC Therapeutics	USD -139.08M	116.01M	2025-12
Qiagen NV	USD 134.73M	7.91M	2025-09
Regeneron Pharmaceuticals	USD 1.76B	244.6M	2025-09
Roche Holding	CHF 4.79B	3.01B	2025-06
Sarepta Therapeutics	USD -407.67M	213.63M	2025-12
Sartorius	EUR 85M	14.1M	2025-09
Tilray	USD -1.39B	600.71M	2025-03
Ultragenyx Pharmaceutical	USD -128M	51.54M	2025-12
Vertex Pharmaceuticals	USD 1.3B	15.8M	2025-09
Zz Pientze Pharmaceu	CNY 523.11M	659.54M	2025-06

Ionis Pharmaceuticals Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.